Trials / Completed
CompletedNCT00488449
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
A Two-Part Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Oral Doses of GSK256073A, in a Randomized, Single-Blind, Dose Escalation Study in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK256073A tablets |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2007-06-20
- Last updated
- 2012-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00488449. Inclusion in this directory is not an endorsement.